Pharmaceutical Research and Manufacturers of America (PhRMA)
950 F Street, NW
44 articles about Pharmaceutical Research and Manufacturers of America (PhRMA)
The Inflation Reduction Act, which is expected to have wide-ranging implications for the pharmaceutical industry, will still need to go to the House of Representatives.
The bill may lead to a 15% to 25% reduction in expected returns for drugs in the top quintile of expected returns. Meaning a decrease in new medications entering the market in the following years.
Vaccine Approval Important Step Forward Against Pandemic, Reminder of What's at Stake in Drug Pricing Debate
Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl made the following statement after the U.S. Food and Drug Administration approved the first COVID-19 vaccine.
A new report from the Pharmaceutical Research and Manufacturers of America uncovers the system of incentives that lead hospitals to drive up costs for patients and employers by marking up the price of medicines.
The Pharmaceutical Research and Manufacturers of America named Debra DeShong as executive vice president of public affairs.
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced first-ever, industry-wide principles on clinical trial diversity. The principles focus on four main areas: building trust and acknowledging the historic mistrust of clinical trials within Black and Brown communities, reducing barriers to clinical trial a
As part of the biopharmaceutical industry's commitment to advance diversity and inclusion in the workplace, president and chief executive officer Stephen J. Ubl of the Pharmaceutical Research and Manufacturers of America signed the CEO Action for Diversity & Inclusion Pledge.
Hospitals participating in the 340B drug pricing program are reimbursed for physician-administered medicines at a rate that is on average three times what they paid to acquire the medicine, according to a new analysis conducted by Milliman and commissioned by the Pharmaceutical Research and Manufacturers of America.
International Reference Pricing Provisions in Plan Would Decimate Development of Innovative Medicines by Nearly 90%
9/6/2019Biopharma companies strengthen the C-suite and board of directors with these appointments.
Giovanni Caforio, M.D., chairman and CEO of Bristol-Myers Squibb has assumed the role of chairman of the PhRMA board of directors.
The study data shows that the amount hospitals receive after negotiations with commercial payers is, on average, almost twice what they paid to acquire the medicine.
Eighty-six percent of AARP members support the administration's proposed rule to reform the rebate system in Medicare Part D, according to a nationwide Morning Consult survey commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery
Contributing to both the Cancer and Inflammation and Immunity Steering Committees
The study found at least seven significant economic contributions of biopharmaceutical manufacturing.
Giovanni Caforio, M.D., Chairman of the Board and CEO, Bristol-Myers Squibb Company and David Ricks, Chairman and CEO, Eli Lilly and Company, assume new posts
U.S. Senate Spending Bill Calls for TV Ad Price Disclosure of Drugs, Increases Spending on Alzhei...
8/24/2018A spending bill passed in the U.S. Senate includes provisions taking aim at the high cost of prescription medicines by requiring pharmaceutical companies to disclose the cost of medications in television advertisements.
The PhRMA today announced a new multi-year, multimillion dollar initiative to address the opioid crisis, which will include a partnership with the Addiction Policy Forum to fund state and local programs, as well as support for new public policies that help families and individuals impacted by the crisis.
Brian Toohey To Lead International Advocacy At Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Research and Manufacturers of America (PhRMA) Release: New Report: Decade Of Breakthroughs In Cancer